DNMT1 and neoplasm: Notably, abrogation of DNMT1 did not interfere with ALK levels or activity in ALKKO transgenic mice as indicated by similar pALK levels in ALK tumor cells and ALKKO thymocytes nor did it change pSTAT3 levels (Fig 3E).